Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02326337 · ClinicalTrials.gov registry record · NA
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A NA study, sponsored by AOTI.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT02326337 is a NA study that has completed, run by AOTI. The registered enrollment target is 73 participants.
The verdict
NCT02326337, a NA study, has completed, sponsored by AOTI.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy, safety and economical benefits of Cyclical Pressure Topical Wound Oxygen (TWO2) Therapy in the treatment of chronic diabetic foot ulcers. Subjects will wear a standardized off-loading device and use advanced moist wound therapy (AMWT) dressings. Following a 2 week run-in period with the standardized care and after meeting all the eligibility criteria, half the subjects will use the TWO2 device, while the other half will use a sham device.
Interventions
- DEVICE Placebo Device
- DEVICE TWO2 Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-10-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02326337
The ClinicalTrials.gov registry entry for NCT02326337 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AOTI, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Device is the first listed.
NCT02326337 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02326337 about?
NCT02326337 is a clinical study titled "Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers". The purpose of this study is to evaluate the efficacy, safety and economical benefits of Cyclical Pressure Topical Wound Oxygen (TWO2) Therapy in the treatment of chronic diabetic foot ulcers. Subjects will wear a standardized off-loading device and use advanced moist wound therapy (AMWT) dressings....
What is the current status of trial NCT02326337?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2014-10. Estimated completion is 2018-10-25.
What interventions are being tested in trial NCT02326337?
The interventions under investigation include: Placebo Device (DEVICE), TWO2 Device (DEVICE).
Who is sponsoring clinical trial NCT02326337?
This trial is sponsored by AOTI, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.